Aquestive Therapeutics, Inc. Liquidation Value
AQST
Other
Cash & Equivalents
$121.17M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $121.17M
Total Obligations: -$97.69M
$23.48M
Per share: $0.19
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $121.17M
AR: $18.39M
Total Obligations: -$97.69M
$41.87M
Per share: $0.34
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $121.17M
AR: $18.39M
Inventory: $6.17M
Total Obligations: -$97.69M
$48.04M
Per share: $0.39
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $23.48M | $0.19 |
| Liquid Liquidation Value | $41.87M | $0.34 |
| Operating Liquidation Value | $48.04M | $0.39 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $121.17M |
| Accounts Receivable | $18.39M |
| Inventory | $6.17M |
| Current Liabilities | $47.61M |
| Long-term Debt | $45.00M |
| Op. Lease Liability | $4.97M |
| Finance Lease | $113,000 |
| Shares Outstanding | 122.0M |
Explore all 156 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $121.17M | $18.39M | $6.17M | $29.86M | $47.61M | $45.00M | $4.97M | $113,000 |
| 2025-09-30 | $129.06M | $3.00M | $7.88M | $10.87M | $25.57M | $45.00M | $5.11M | N/A |
| 2025-06-30 | $60.54M | $2.85M | $8.12M | $11.95M | $23.16M | $45.00M | $5.24M | N/A |
| 2025-03-31 | $68.66M | $2.93M | $7.20M | $12.28M | $18.30M | $45.00M | $5.36M | N/A |
▼ Community Notes